Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT newswireMT newswire2026/08/24 12:55
08:55 AM EDT, 08/24/2026 (MT Newswires) -- Biogen (BIIB) and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease. The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease. The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver. LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03

Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.

On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.

华尔街见闻•2026/11/10 23:01
Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.